· Published by Health Canada · Official notice
This is a duplicated text of a letter from Hospira Healthcare Corporation. Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
May 16, 2014
Dear Chief of Medical Staff and Director of Pharmacy
Please distribute to relevant Departments (Oncology, Pharmacy, Geriatrics, Internal Medicine, Nursing, Paediatrics, Intensive Care Unit, Coronary Care, Emergency Department, Surgery, Anaesthesia, Recovery Room and/or other Departments as required), and other involved professional staff and post this Notice in the relevant areas of your institution.
Subject: Recall of one lot of Hospira Sodium Chloride 0.9% Irrigation, USP, 3000 mL flexible container (DIN 00037826, Lot 29037JT) due to potential leakage of bags.
Hospira Healthcare Corporation, in consultation with Health Canada, is recalling one lot (Lot 29037JT) of Sodium Chloride 0.9% Irrigation, USP, 3000 mL flexible container due to the potential for leakage of the bags. During visual inspection, Hospira identified primary bag leaks.
Leaking bags of Sodium Chloride 0.9% Irrigation, USP may result in compromised sterility and potential for contamination.
Product impacted by this issue is listed below:
Description - Sodium Chloride 0.9% Irrigation, USP, 3000mL
DIN - 00037826
List Number - 07972259
Lot No. - 29037JT
Expiry Date - May 1, 2015
Managing marketed health product-related adverse reactions depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse reactions are generally presumed to underestimate the risks associated with health product treatments. Any cases of serious adverse reaction or other serious or unexpected adverse reactions in patients receiving Sodium Chloride 0.9% Irrigation, USP should be reported to Hospira Healthcare Corporation or Health Canada at the following addresses:
Hospira Healthcare Corporation
1111 Dr.-Frederik-Philips, Suite 600
Saint-Laurent (Québec) H4M 2X6
To report an Adverse Reaction, consumers and health professionals may call toll free :
Tel: 1-866-488-6088 Option 6
Fax: 1-877-906-0208
ProductcomplaintsCA@hospira.com
To correct your mailing address or fax number, contact Hospira Healthcare Corporation.
You can report any suspected adverse reactions associated with the use of health products to Health Canada by:
For other health product inquiries related to this communication, please contact Health Canada at:
Health and Product and Food Branch Inspectorate
E-mail: DCVIU_UVCEM@hc-sc.gc.ca
Telephone: 1-800-267-9675
Fax: 1-613-946-5636.
Sincerely,
Original signed by
Rania Al-Ammar
Regional Director, Commercial Quality
Hospira Healthcare Corporation